Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a report released on Sunday morning. The brokerage issued a hold rating on the medical research company’s stock.

Enzo Biochem Stock Down 2.9 %

Shares of Enzo Biochem stock opened at $0.64 on Friday. Enzo Biochem has a 52-week low of $0.62 and a 52-week high of $1.40. The firm’s 50 day moving average price is $0.82 and its 200-day moving average price is $1.02.

Enzo Biochem (NYSE:ENZ) last released its earnings results on Monday, December 16th. The medical research company reported ($0.05) earnings per share for the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Institutional Trading of Enzo Biochem

Several large investors have recently bought and sold shares of ENZ. Renaissance Technologies LLC boosted its holdings in shares of Enzo Biochem by 2.6% in the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock valued at $2,725,000 after acquiring an additional 64,417 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Enzo Biochem by 3.3% in the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after acquiring an additional 11,742 shares during the last quarter. BBR Partners LLC purchased a new stake in shares of Enzo Biochem in the 3rd quarter valued at $112,000. Finally, XTX Topco Ltd boosted its holdings in shares of Enzo Biochem by 94.5% in the 2nd quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock valued at $31,000 after acquiring an additional 13,735 shares during the last quarter. Hedge funds and other institutional investors own 36.90% of the company’s stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.